Εμφανίζονται 1 - 20 Αποτελέσματα από 120 για την αναζήτηση '"Advanced control systems"', χρόνος αναζήτησης: 1,08δλ Περιορισμός αποτελεσμάτων
  1. 1
    Conference

    Πηγή: 2024 8th International Conference on Smart Grid and Smart Cities (ICSGSC) Smart Grid and Smart Cities (ICSGSC), 2024 8th International Conference on. :275-285 Oct, 2024

    Relation: 2024 8th International Conference on Smart Grid and Smart Cities (ICSGSC)

  2. 2
    Conference

    Συγγραφείς: Rus, Cosmin, Leba, Monica

    Πηγή: 2024 International Conference on Computing in Natural Sciences, Biomedicine and Engineering (COMCONF) COMCONF Computing in Natural Sciences, Biomedicine and Engineering (COMCONF), 2024 International Conference on. :30-35 Aug, 2024

    Relation: 2024 International Conference on Computing in Natural Sciences, Biomedicine and Engineering (COMCONF)

  3. 3
  4. 4
  5. 5
    eBook

    Συγγραφείς: Brochard, AliaumeAff14, Aff15, Pasillas-Lépine, WilliamAff14, Demaya, BernardAff15

    Συνεισφορές: Chaari, Fakher, Series EditorAff1, Gherardini, Francesco, Series EditorAff2, Ivanov, Vitalii, Series EditorAff3, Haddar, Mohamed, Series EditorAff4, Cavas-Martínez, Francisco, Editorial Board MemberAff5, di Mare, Francesca, Editorial Board MemberAff6, Kwon, Young W., Editorial Board MemberAff7, Tolio, Tullio A. M., Editorial Board MemberAff8, Trojanowska, Justyna, Editorial Board MemberAff9, Schmitt, Robert, Editorial Board MemberAff10, Xu, Jinyang, Editorial Board MemberAff11, Huang, Wei, editorAff12, Ahmadian, Mehdi, editorAff13

    Πηγή: Advances in Dynamics of Vehicles on Roads and Tracks III : Proceedings of the 28th Symposium of the International Association of Vehicle System Dynamics, IAVSD 2023, August 21–25, 2023, Ottawa, Canada - Volume 1: Rail Vehicles. :269-278

  6. 6
  7. 7
  8. 8
  9. 9
    Academic Journal
  10. 10
    Conference

    Πηγή: 2016 9th International Conference on Human System Interactions (HSI) Human System Interactions (HSI), 2016 9th International Conference on. :289-295 Jul, 2016

    Relation: 2016 9th International Conference on Human System Interactions (HSI)

  11. 11
  12. 12
    Other Literature Type

    Συγγραφείς: JALALI, SEYED RASOUL

    Θεματικοί όροι: preterm birth, neonatal mortality, neonatal morbidity, ψ–Hamzah model, Hamzah equation, fractal–fractional calculus, complex integral transform, nanoparticle vaccine, nanomedicine, preterm complications, neonatal intensive care, neonatal immunology, neonatal pharmacology, neonatal regenerative medicine, neonatal lungs, neonatal brain, neonatal neuroprotection, neonatal surfactant deficiency, respiratory distress syndrome, premature infants, neonatal hypoxia, neonatal sepsis, neonatal inflammation, neonatal immune modulation, neonatal growth factors, neonatal VEGF, neonatal BDNF, neonatal NGF, neonatal FGF-10, surfactant proteins, SP-A, SP-B, SP-C, nanocarriers, PLGA nanoparticles, liposomal nanocarriers, fractal adjuvants, fractal immunology, Koch fractal adjuvant, Sierpinski microfluidics, nanoparticle pharmacokinetics, nanoparticle pharmacodynamics, PK/PD modelling, bioavailability, drug release kinetics, immune activation, T cell activation, B cell activation, neonatal macrophages, neonatal dendritic cells, neonatal adaptive immunity, neonatal innate immunity, cytokine modulation, IL-6 modulation, TNF-alpha modulation, CRP modulation, oxygen regulation, hypoxia markers, neonatal oxidative stress, neonatal apoptosis, neonatal necrosis, neonatal brain injury, intraventricular haemorrhage, periventricular leukomalacia, neonatal epilepsy, neonatal neurodevelopment, developmental disorders, cerebral palsy prevention, neonatal long-term outcomes, neonatal quality of life, neonatal survival index, therapeutic index, high therapeutic index, safety index, clinical safety, clinical efficacy, nanoparticle safety, biocompatibility, systemic toxicity, systemic inflammation, immunotoxicity, PK stability, PD optimisation, controlled drug release, controlled vaccine release, mathematical modelling, computational pharmacology, computational immunology, systems biology, bioinformatics, medical nanotechnology, regenerative biology, neonatal stem cells, neonatal regenerative potential, fractal dynamics, fractional derivatives, fractional integrals, fractional-order models, complex bio-kernels, bio-memory modelling, stochastic bio-systems, neonatal multi-scalar dynamics, multi-scalar modelling, neonatal tissue regeneration, lung alveolar development, brain axonal growth, myelination, angiogenesis, neurogenesis, alveologenesis, alveolar surfactant synthesis, alveolar stability, respiratory epithelium, blood-brain barrier, neonatal pharmacoresistance, drug resistance modelling, mutation modelling, neonatal genome diversity, neonatal proteomics, neonatal transcriptomics, neonatal metabolomics, omics integration, neonatal systems medicine, neonatal AI modelling, neonatal digital twin, neonatal predictive modelling, neonatal therapeutic simulation, neonatal scenario testing, 100 scenarios testing, trillion scenario modelling, clinical translation, preclinical validation, neonatal trial design, WHO neonatal health, UNICEF neonatal health, neonatal global health, neonatal survival programme, neonatal healthcare policy, neonatal biotechnology, neonatal biomedical innovation, neonatal translational research, neonatal interdisciplinary science, neonatal medical engineering, neonatal bioengineering, neonatal nanobiology, neonatal microfluidics, neonatal fractal microfluidics, neonatal in vitro simulation, neonatal bioreactor, neonatal artificial placenta, neonatal artificial womb, neonatal ex vivo perfusion, neonatal real-time biosensing, neonatal Raman spectroscopy, neonatal electrochemical biosensing, neonatal flow cytometry, neonatal omics biosensing, neonatal data integration, neonatal computational intelligence, neonatal deep learning, neonatal machine learning, neonatal AI healthcare, neonatal algorithmic medicine, neonatal adaptive therapy, neonatal personalised medicine, neonatal precision medicine, neonatal tailored vaccine, neonatal tailored drug therapy, neonatal adaptive drug release, neonatal drug safety, neonatal vaccine safety, neonatal efficacy assurance, neonatal zero adverse effects, neonatal near-zero toxicity, neonatal long-memory processes, neonatal fractal-fractional simulation, neonatal complex integral equations, neonatal multidimensional control, neonatal stochastic integration, neonatal immunoengineering, neonatal bioengineering frameworks, neonatal mathematical biology, neonatal computational biology, neonatal applied mathematics, neonatal nanopharmacology, neonatal immunopharmacology, neonatal pharmacodynamics, neonatal pharmacokinetics, neonatal clinical pharmacology, neonatal biophysics, neonatal biochemistry, neonatal molecular biology, neonatal therapeutic biology, neonatal biotechnology engineering, neonatal translational biology, neonatal therapeutics, neonatal vaccine innovation, neonatal drug innovation, neonatal immune engineering, neonatal tolerance induction, neonatal immune stability, neonatal multi-organ modelling, neonatal systemic safety, neonatal systemic regulation, neonatal stability protocols, neonatal advanced control systems, neonatal PID controllers, neonatal feedback loops, neonatal biological controllers, neonatal advanced biocontrol, neonatal environmental simulation, neonatal clinical simulation, neonatal artificial intelligence simulation, neonatal computational scenario testing, neonatal extreme case testing, neonatal adverse effect reduction, neonatal toxicity minimisation, neonatal safety maximisation, neonatal survival probability, neonatal probability modelling, neonatal statistical validation, neonatal clinical statistics, neonatal Bayesian modelling, neonatal predictive analytics, neonatal machine learning models, neonatal deep reinforcement learning, neonatal advanced AI systems, neonatal high-performance computing, neonatal parallel computing, neonatal computational acceleration, neonatal quantum simulation, neonatal advanced algorithms, neonatal global health modelling, neonatal worldwide survival, neonatal infant health policy, neonatal humanitarian health, neonatal innovation ecosystem, neonatal patent protection, neonatal intellectual property, neonatal WIPO registration, neonatal international collaboration, neonatal interdisciplinary research, neonatal science diplomacy, neonatal translational medicine, neonatal advanced vaccine engineering, neonatal advanced drug engineering, neonatal nanodrug design, neonatal immune nanodesign, neonatal advanced systems engineering, neonatal fractal systems, neonatal fractional-order systems, neonatal chaos modelling, neonatal nonlinear dynamics, neonatal adaptive fractal control, neonatal integrative dynamics, neonatal hybrid modelling, neonatal multiscale control, neonatal clinical integration, neonatal therapeutic integration, neonatal adaptive personalised therapy, neonatal nanovaccine safety, neonatal nanodrug safety, neonatal nanomedicine validation, neonatal global validation, neonatal health implementation, neonatal WHO strategy, neonatal UNICEF strategy, neonatal SDG3 health, neonatal sustainable health, neonatal innovation strategy, neonatal future medicine, neonatal biomedical paradigm, neonatal paradigm shift, ψ–Hamzah paradigm, Hamzah biomedical innovation, Hamzah biomedical paradigm, ψ–Hamzah vaccine, ψ–Hamzah drug, ψ–Hamzah cancer application, ψ–Hamzah neonatal application, ψ–Hamzah universal medicine, ψ–Hamzah advanced therapy, ψ–Hamzah nanotherapy, ψ–Hamzah nanovaccine, ψ–Hamzah anti-cancer therapy, ψ–Hamzah zero toxicity, ψ–Hamzah maximal efficacy, ψ–Hamzah trillion scenarios, ψ–Hamzah predictive model, ψ–Hamzah computational biology, ψ–Hamzah applied mathematics, ψ–Hamzah systems medicine, ψ–Hamzah biomedical future, ψ–Hamzah translational science, ψ–Hamzah paradigm shift

  13. 13
  14. 14
    Periodical

    Πηγή: Utility Automation & Engineering T&D. Jan/Feb2006, Vol. 11 Issue 1, p34-38. 4p.

    Θεματικοί όροι: Exhibitors

  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20